StartupsTechCrunchabout 1 hour ago
Proximal Ventures raises $27.5M AI drug fund
2 min read
Proximal Ventures, a new firm led by Sahir Raoof, raises $27.5 million to back startups applying AI to drug development. The fund targets pre-seed and seed-stage companies with checks ranging from $500,000 to $1.5 million. Backers include SignalFire, Kleiner Perkins, and former FDA official Amy Abernethy, betting that AI can automate pharmaceutical services to reduce costs and time.
Level
Hype check
Tap to vote and see what everyone thinks.